Key takeaways
The Medicare GLP-1 Bridge is a temporary program that runs from July 1, 2026 to December 31, 2027 and allows eligible people with Medicare drug coverage to pay $50 per month for certain weight-loss GLP-1 medications.
The program includes Foundayo, Wegovy, and the Zepbound KwikPen. Ozempic and Mounjaro are excluded since they’re approved for Type 2 diabetes, not weight loss.
There is no guarantee that coverage will continue beyond 2027, and the $50 copay does not count toward your Part D deductible or the yearly out-of-pocket limit.
Weight-loss medications have historically been left out when it comes to Medicare Part D coverage. However, with obesity becoming widely recognized as a complex disease and the use of GLP-1 medications rapidly expanding, the Medicare GLP-1 Bridge program now offers a massive discount on these drugs. This new $50 GLP-1 benefit from Medicare is welcome news for many people with Medicare, but it comes with specific criteria and is meant to be temporary. Many people also find themselves lost if they don’t qualify. Here’s how it works, who it covers, what it costs, and what your options look like if it doesn’t apply to you.
What is the Medicare GLP-1 Bridge program?
The Medicare GLP-1 Bridge is a short-term demonstration program run by the Centers for Medicare & Medicaid Services (CMS). It was created to help expand access and coverage for GLP-1 medications approved for weight management.
As the name suggests, it’s supposed to help bridge the gap between current coverage for GLP-1s used to treat conditions other than obesity and a more long-term solution for weight-loss drug coverage. That’s because current federal law has prevented Medicare from covering medications used for weight loss. This demonstration program helps bypass those restrictions while CMS works out a longer-term plan.
The program is scheduled to be active from July 1, 2026 to December 31, 2027. Pharmacies bill Bridge prescriptions to a separate central processor rather than your drug plan. For this reason, the $50 cost doesn’t count toward a plan’s deductible or your annual out of pocket maximum.
Who is eligible for the Medicare GLP-1 Bridge program?
You need to have Medicare drug coverage, which means having either a standalone Part D plan or a Medicare Advantage plan with prescription drug coverage. Other than that, you need to be 18 or older and meet one of the following criteria:
- A BMI of 35 or higher
- A BMI of 30 or higher, with diastolic heart failure, uncontrolled high blood pressure, or chronic kidney disease at stage 3a or above
- A BMI of 27 or higher, with prediabetes, a previous heart attack or stroke, or peripheral artery disease with symptoms
If you have Type 2 diabetes, obstructive sleep apnea, or MASH (a form of fatty liver disease), you aren’t eligible for the Bridge, since those are already Medicare-covered uses. You’re also not able to use the Bridge program if you already get a GLP-1 medication through your Part D plan.
Which GLP-1 drugs are covered under the Bridge program?
The GLP-1 Bridge program currently covers the following for weight loss:
- Foundayo (orforglipron), a once-daily tablet
- Wegovy (semaglutide), both the injection and the tablet
- Zepbound (tirzepatide), the KwikPen only
If you currently use Zepbound vials or single-dose pens, your prescription would need to be switched to the KwikPen in order to get coverage through the Bridge program. Other medications in the GLP-1 agonist class aren’t part of the program at all.
How much does the Medicare GLP-1 Bridge program cost?
The cost for a one-month supply (28 or 30 days) of a covered GLP-1 drug is $50, which is the price regardless of a person’s income. There are no 60- or 90-day fills allowed through the program.
A few things to keep in mind about the program:
- Part D deductibles don’t apply to Bridge prescriptions.
- The $50 doesn’t count toward the yearly out-of-pocket limit for covered Part D drugs, which is $2,100 in 2026 and $2,400 in 2027.
- Extra Help, the low-income subsidy that reduces drug costs for some people, can’t be used on top of the Bridge program.
This program demonstration is separate from regular prescription coverage. If you spend $600 over a year through this program, it doesn’t count toward the out-of-pocket cap.
How do you enroll in the Medicare GLP-1 Bridge program?
There’s no enrollment process. You don’t sign up, and your drug plan doesn’t have to opt in. Any eligible person with Part D or a Medicare Advantage plan that includes drug coverage can use it.
Here’s how it works:
- Talk with your healthcare provider about whether a covered GLP-1 is right for you and whether you meet the criteria.
- Your healthcare provider sends the prescription to your pharmacy.
- The pharmacy bills the Bridge program and requests prior authorization from your prescriber.
- Your prescriber completes the prior authorization, showing that you meet the criteria.
- Medicare sends you a confirmation letter, your pharmacy sends you a notification, and you pick up the prescription for $50.
Once your first fill is approved, later refills don’t need a new prior authorization unless you switch to a different covered GLP-1. Approvals are valid through Dec. 31, 2027. There’s no appeals process if a request is denied, although your healthcare provider can submit the correct information if needed.
What if you don’t qualify or your GLP-1 isn’t covered?
Not everyone qualifies for this program, and it can be disheartening to see you were denied. You may want to follow up to see what the reason is, since you might not meet the criteria. For example, you might already be on a GLP-1 for a condition other than obesity, or you’re using Zepbound vials instead of the KwikPen.
If that’s you, it may be a good idea to check the price with other savings options like the SingleCare coupon. The SingleCare discount is for the retail cost and is not considered insurance. Prices vary by location, so check the coupon page for your specific medication and dose.
One thing to keep in mind: you can’t combine a SingleCare coupon with Medicare on the same prescription, whether or not you use the Bridge program or standard Part D coverage. You either pay with Medicare coverage or pay cash with a coupon.
What happens after the Medicare GLP-1 Bridge program ends in 2027?
There’s no guarantee that this program will last beyond 2027. However, CMS is developing a longer-term program called the BALANCE model, which will eventually provide coverage for GLP-1s for weight loss. Part D plans will have the option to participate.
In April 2026, CMS delayed the BALANCE program for 2027. Their goal is to collect more data regarding the Bridge program and its results. For those starting a GLP-1 through the Bridge program, it’s important to look at the potential costs and make plans in case coverage changes in 2028. That way there are no surprises later on.
Bottom line
The Medicare GLP-1 Bridge can help lower the costs of GLP-1 medications for weight loss. Up until this program, many people have had to pay high out-of-pocket costs for GLP-1 medications due to a lack of Medicare coverage. However, the Bridge program is temporary, requires certain criteria to be met, and only covers specific GLP-1 products. If you don’t qualify, or the program ends without a replacement, it can be a good idea to know your options, such as a prescription savings card.
Frequently asked questions
Do I need to submit the Medicare GLP-1 Bridge prior authorization paperwork myself?
No, patients don’t submit paperwork for prior authorizations. The pharmacy will notify your healthcare provider if prior authorization is needed before they can fill a prescription. However, you can also notify your healthcare provider to help speed up the process.
Does the Medicare GLP-1 Bridge program cover Ozempic or Mounjaro?
The program only covers Foudayo, Wegovy, and the Zepbound KwikPen. Ozempic and Mounjaro are approved for Type 2 diabetes rather than weight management, so they’re not included in the program.
Can I use the Medicare GLP-1 Bridge program and a SingleCare coupon at the same time?
No, you can’t use a SingleCare coupon on top of the GLP-1 Bridge program. You have to choose one or the other per fill. A SingleCare coupon can be useful if you don’t qualify for the Bridge program.
Bottom line
The Medicare GLP-1 Bridge can help lower the costs of GLP-1 medications for weight loss. Up until this program, many people have had to pay high out-of-pocket costs for GLP-1 medications due to a lack of Medicare coverage. However, the Bridge program is temporary, requires certain criteria to be met, and only covers specific GLP-1 products. If you don’t qualify, or the program ends without a replacement, it can be a good idea to know your options, such as a prescription savings card.
- Medicare GLP-1 Bridge, Centers for Medicare & Medicaid Services (2026)
- Weight loss drugs, Medicare.gov (2026)
- BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) Model, Centers for Medicare & Medicaid Services (2026)
- Status update: Medicare GLP-1 Bridge demonstration and BALANCE model Part D for CY2027, Centers for Medicare & Medicaid Services (2026)
- Announcement of calendar year 2027 Medicare Advantage capitation rates and Part C and Part D payment policies, Centers for Medicare & Medicaid Services (2026)
- Medically accurate: SingleCare’s Medical Review Board analyzes all of our content to confirm it’s in line with current medical advice.
- Evidence-based: Our content is sourced from reputable U.S.-based healthcare professionals and peer-reviewed research.
- Trustworthy: All of SingleCare’s content goes through a multi-phase review process by our writers, editors, and Medical Board in order to provide clear and credible information.